Abstract
Darunavir/cobicistat/emtricitabine/tenofovir AF (Symtuza (R)) is the first protease inhibitor (PI)-based single-tablet regimen (STR) available for the......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
